Quality monitoring, standardized documentation and management with a computerized system in oncology

Autor: Beinert T, Dubiel M, Hg, Mergenthaler, Fleischhacker M, Bruhn N, Dingeldein G, Helle A, Lüftner D, Kd, Wernicke, Flath B, Akrivakis C, Sezer O, Novopashenny I, Manfred Wischnewsky, Possinger K

Publikováno v: Europe PubMed Central

Within the last years the prerequisite was prepared to develop a computerized tumor--patient documentation system including quality monitoring and oncological therapy recommendations for every day use. In medicine today, there is an increasing need f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0af9038544a99cff2d0860ddbfb09ade
http://europepmc.org/abstract/med/10179738

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Autor: Knop S; Department of Internal Medicine II, Division of Hematology and Medical Oncology, Würzburg University Medical Centre, Würzburg, Germany., Engelhardt M; Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Centre, Freiburg, Germany., Liebisch P; Klinik für Innere Medizin III, Ulm University Hospital, Ulm, Germany., Meisner C; Institute for Clinical Epidemiology and Applied Biometry, Tübingen University Medical School, Tübingen, Germany., Holler E; Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Metzner B; University Clinic for Internal Medicine - Oncology and Haematology, Oldenburg, Germany., Peest D; Department of Hematology, Oncology and Haemostaseology, Hanover Medical School, Hanover, Germany., Kaufmann M; Medical Centre, Robert-Bosch-Hospital, Stuttgart, Germany., Bunjes D; Klinik für Innere Medizin III, Ulm University Hospital, Ulm, Germany., Straka C; Hematology, Oncology and Infectiology, Munich Schwabing Hospital, Munich, Germany., Fischer T; Department of Hematology and Oncology, Centre of Internal Medicine, Otto-von-Guericke University, Magdeburg, Germany., Sezer O; Department of Hematology/Oncology, Charite - Oncology Centre, Berlin, Germany., Hentrich M; Hematology and Oncology, Red Cross Hospital, Munich, Germany., Ostermann H; Department of Hematology, University Hospital Grosshadern, Munich, Germany., Bassermann F; IIIrd Department of Internal Medicine, Hematology/Oncology, Technical University, Munich, Germany., Hess G; Department of Hematology, Oncology and Pneumology, Universitätsmedizin Mainz, Mainz, Germany., Hertenstein B; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany., Freund M; Hematology, Oncology, Palliative Medicine, University of Rostock, Rostock, Germany., Kropff M; Hematology and Oncology, University of Munster, Munster, Germany., Schmidt CA; Department of Internal Medicine, Greifswald University Hospital, Greifswald, Germany., Wolf HH; Department of Hematology and Oncology, University Hospital, Halle, Germany., Jung W; Hematology and Oncology, Zentrum Innere Medizin, Gottingen, Germany., Frickhofen N; Hematology/Oncology, HSK, Dr. Horst-Schmidt-Klinik, Wiesbaden, Germany., Mielke S; Department of Internal Medicine II, Division of Hematology and Medical Oncology, Würzburg University Medical Centre, Würzburg, Germany.; Department of Laboratory Medicine, CAST, Karolinska Institutet and University Hospital, Stockholm, Sweden., Bargou RC; Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany., Maschmeyer G; Department of Hematology, Oncology and Palliative Care, Ernst von Bergmann Hospital, Potsdam, Germany., Svaldi M; Bolzano Municipal Hospital, Bolzano, Italy., Langer CH; Klinik für Innere Medizin III, Ulm University Hospital, Ulm, Germany., Gramatzki M; Department of Stem Cell Transplantation and Immunotherapy, Schleswig-Holstein University Hospital, Kiel Campus, Kiel, Germany., Hebart H; Department of Internal Medicine, Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany., Kanz L; Department for Oncology, Hematology, Immunology, Rheumatology and Pneumology, University Hospital, Tübingen, Germany., Einsele H; Department of Internal Medicine II, Division of Hematology and Medical Oncology, Würzburg University Medical Centre, Würzburg, Germany. einsele_h@ukw.de.

Publikováno v: Leukemia [Leukemia] 2019 Nov; Vol. 33 (11), pp. 2710-2719. Date of Electronic Publication: 2019 Aug 28.

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.

Autor: Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S

Publikováno v: Annals of hematology [Ann Hematol] 2014 Jul; Vol. 93 (7), pp. 1167-76.

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

Autor: Bennouna J; Institut de Cancérologie de l'Ouest, Nantes, France., Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2013 Jan; Vol. 14 (1), pp. 29-37. Date of Electronic Publication: 2012 Nov 16.

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.

Autor: Eichhorst BF; Department I of Internal Medicine, Centre of Integrated Oncology Köln Bonn, University of Cologne, Cologne, Germany. barbara.eichhorst@uk-koeln.de, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M

Publikováno v: Blood [Blood] 2011 Feb 10; Vol. 117 (6), pp. 1817-21. Date of Electronic Publication: 2010 Dec 07.